Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia. This evidence concerns the gene RUNX1 and B-cell acute lymphoblastic leukemia.